Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation
Nicola Gökbuget(Goethe University Frankfurt), Dieter Hoelzer(Endokrinologikum)
Cited by 464
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
|Blood|2005|537